Skip to content

Compounds · Skin & hair · Melanin production and skin tanning enhancement

Melanotan II (MT2)

Full protocol

MT-II, Melanotan 2, Afamelanotide analog

A synthetic analogue of α-MSH sold illicitly for tanning, with no approval from any major regulator. Case reports from 2020 flagged renal infarction, rhabdomyolysis, and kidney failure, making its use a public-health concern.

0.25–0.5 mg load, then 2–3× weekly

Research score 55/100. Reference only, not a prescription.

  • Skin Tanning
  • Melanin Production
  • Photoprotection
  • Appetite Suppression
  • Libido Enhancement
US status
Research Chemical
Approval
Not Approved
Evidence
Synthetic alpha-MSH analog. Promotes melanogenesis (tanning) and sexual arousal. widely used but unregulated.
Research score
55 / 100
Indication
Research Only - No Medical Indication
Origin
USA
Source category
Skin & Dermatology
Status group
Research chemical

Mechanism

Acts as a potent agonist at MC1R and MC4R; MC1R activation raises cAMP and tyrosinase activity, driving melanin production, while MC4R activation affects appetite and sexual-response pathways.

Safety file

Linked to kidney infarction, rhabdomyolysis, priapism, and possible melanoma risk, along with severe nausea and flushing.

  • Nausea
  • Facial flushing
  • Increased libido
  • Appetite suppression
  • Darkening of existing moles
  • Potential blood pressure changes

Important: Melanotan-2 is not approved anywhere. Regulators have warned about new or changing moles and possible melanoma, and case reports describe priapism, kidney injury and muscle breakdown. Get any changing mole checked.

Reconstitution

Concentration by vial size and water volume
Vial1 mL water2 mL water
10 mg10 mg/mL5 mg/mL
  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.

Full mixing method

Protocol

Route: Subcutaneous

Standard protocol (subcutaneous)

  • Loading: start at 0.25 mg once daily for the first few days to gauge nausea, holding at 0.25 to 0.5 mg daily for 1 to 2 weeks while building colour with sun or UV
  • Maintenance: 0.5 to 1 mg, two to three times weekly
  • At a 2 mL fill on a 10 mg vial (5 mg/mL), 0.25 mg is a 0.05 mL draw (5 units) and 0.5 mg is 0.1 mL (10 units)

Inject at night

  • Nausea and facial flushing are very common, worst during loading and peaking 2 to 4 hours after a dose
  • Dosing in the evening means you sleep through the worst of it

Dosing detail

  • Loading: 0.25 mg daily (start here), up to 0.5 mg, for 1 to 2 weeks. Maintenance: 0.5 to 1 mg, 2 to 3 times weekly.
  • Build colour gradually with sun or UV exposure. The peptide primes tanning; light still does the work.
  • Nausea and flushing are very common early. Start low, dose at night, ease up if it is rough.
  • Do not stack with PT-141 or Melanotan-1. All three act on the same melanocortin system, so combining them is redundant, not better.

Duration

  • Loading phase of 1 to 2 weeks of small daily doses, then occasional maintenance doses to keep the tan.

Notes

  • Causes noticeable nausea and facial flushing, especially at first. Starting low and dosing at night helps.
  • Can darken moles and freckles. Keep an eye on any that change.
  • Inject subcutaneously and rotate sites.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.

Storage rules and when to discard